Matsuyama N, Suzuki K, Tobe T, Ueki H, et al. Time to Oligoprogression From the Initiation of the Most Recent Systemic Treatment Is Associated With the Outcome of Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer. Int J Urol 2025 Sep 2. doi: 10.1111/iju.70217.
PMID: 40898702